
HHS-OIG Advisory Opinion 26-16 offers a timely, fact-specific example of an FQHC’s limited Food-as-Medicine Program for financially needy patients with diabetes or hypertension.
Food-as-Medicine Programs can help health care organizations address nutrition-related barriers that affect chronic-disease management, but offering free food or grocery benefits to patients may raise federal fraud-and-abuse concerns. HHS-OIG Advisory Opinion 26-16 provides a timely, fact-specific example of how a federally qualified health center (FQHC) structured a limited Food-as-Medicine Program for financially needy patients with diabetes or hypertension.
In reviewing the arrangement, the Office of Inspector General (OIG) determined that the free produce and healthy-food vouchers implicated the Federal Anti-Kickback Statute and the Beneficiary Inducements Civil Monetary Penalty. OIG nevertheless concluded that the proposed Food-as-Medicine Program presented a sufficiently low risk of fraud and abuse and declined to impose administrative sanctions on the requesting FQHC based on the certified facts.
What Was the Proposed Food-as-Medicine Program?
Under the proposed six-month program, the FQHC would enroll 50 financially needy patients diagnosed with diabetes or hypertension. The initiative combined nutrition support with clinical services rather than offering unrestricted cash or a broadly available consumer benefit.
Participants would receive one of the following weekly benefits:
- Produce boxes valued at approximately $30; or
- Vouchers valued at approximately $20, redeemable only for approved healthy foods.
In addition to the weekly food benefit, the FQHC would provide nutrition assessments, individualized meal planning, laboratory testing, counseling, and physician oversight. This clinical integration connected the assistance to the participants’ identified health needs and the program’s disease-management objectives.
Why Food-as-Medicine Programs Implicate Federal Fraud-and-Abuse Laws
The produce boxes and vouchers constituted remuneration because they conveyed something of value to patients. When remuneration is offered in connection with federally reimbursable health care, organizations must consider whether it could influence a patient’s selection of a provider or reward referrals or utilization.
OIG’s Legal Analysis of the Food-as-Medicine Program
OIG concluded that the benefits implicated two principal federal authorities:
- Federal Anti-Kickback Statute. The arrangement could generate prohibited remuneration if the parties acted with the requisite intent to induce or reward referrals for, or the ordering of, items or services reimbursable by a Federal health care program.
- Beneficiary Inducements CMP. The benefits could influence a Medicare or Medicaid beneficiary to select the FQHC for federally reimbursable services.
No safe harbor or statutory exception fully protected the arrangement. OIG nevertheless exercised its enforcement discretion because the particular structure and safeguards described by the requestor reduced the risk that the benefits would improperly steer patients, increase Federal program costs, or interfere with clinical decision-making.
Food-as-Medicine Program Compliance Best Practices
Advisory Opinion 26-16 does not create a general safe harbor for Food-as-Medicine Programs. It does, however, highlight practical safeguards that FQHCs, hospitals, clinics, health systems, and other organizations should evaluate when designing nutrition-support benefits for patients:
- Define objective eligibility standards. Use documented financial-need and clinical criteria rather than referral volume, payer status, or anticipated service use.
- Connect assistance to an identified health need. Design the benefit to support a defined care plan or disease-management objective.
- Limit value, duration, and scope. A modest, time-limited benefit is generally easier to distinguish from an inducement intended to retain or attract patients.
- Restrict how the benefit may be used. Vouchers should be limited to approved items and should not be redeemable for cash or unrelated goods.
- Avoid promotional use. Marketing a free benefit to prospective patients may increase steering concerns.
- Separate enrollment from referral generation. Staff compensation and program eligibility should not depend on referrals, utilization, or Federal health care program business.
- Document clinical and compliance oversight. Written policies should address screening, enrollment, benefit distribution, monitoring, exceptions, and corrective action.
- Review funding relationships. Grants, vendors, donors, and affiliated entities may introduce additional AKS, tax, privacy, or conflict-of-interest issues.
Limits of OIG Advisory Opinion 26-16
OIG advisory opinions bind only the requesting party and only with respect to the arrangement described in the request. OIG relied on facts certified by the requestor and did not independently investigate them. A material change, omission, or misrepresentation could eliminate the opinion’s protective effect.
Organizations considering similar programs should conduct an independent analysis of the AKS, the Beneficiary Inducements CMP, applicable exceptions and safe harbors, state fraud-and-abuse laws, Medicaid requirements, grant restrictions, privacy obligations, and any tax-exemption considerations. A favorable opinion for one arrangement should not be treated as blanket approval for another.
Legal Review of Food-as-Medicine Programs
Health care counsel can help structure Food-as-Medicine Programs and related patient-assistance initiatives before implementation. A legal and compliance review should align eligibility criteria, benefit limits, funding terms, clinical workflows, patient communications, recordkeeping, and monitoring controls with the organization’s regulatory risk profile.
A focused legal review is particularly important when a program is advertised to prospective patients, supported by vendors or manufacturers, available primarily to Federal health care program beneficiaries, or tied to services billed to Medicare or Medicaid.
Frequently Asked Questions About Food-as-Medicine Programs
What is a Food-as-Medicine Program?
A Food-as-Medicine Program uses nutrition-related benefits—such as produce boxes, healthy-food vouchers, medically tailored meals, or nutrition counseling—to support a patient’s treatment plan or chronic-disease management. Program design, eligibility, funding, and the relationship to reimbursable services can affect the legal analysis.
Are Food-as-Medicine Programs permitted under federal law?
Federal law does not categorically prohibit Food-as-Medicine Programs. However, free or discounted patient benefits may constitute remuneration and can implicate the Anti-Kickback Statute or the Beneficiary Inducements CMP. Each arrangement requires a fact-specific review of its purpose, safeguards, eligibility standards, value, marketing, and connection to federally reimbursable services.
Does Advisory Opinion 26-16 protect every similar program?
No. OIG advisory opinions apply only to the requesting party and the specific arrangement described. Other organizations may use the opinion as compliance guidance, but they cannot rely on it as legal protection for a different Food-as-Medicine Program.
Source: HHS-OIG Advisory Opinion 26-16, issued July 9, 2026, and posted July 14, 2026.
This article is for general informational purposes only and does not constitute legal advice. Because advisory opinions are fact-specific and legally binding only on the requesting party, organizations should consult qualified counsel regarding their own arrangements.


